Keywords: good, progress, italy, chiesi, group, italian, pharmaceutical
GOOD PROGRESS FOR ITALY'S CHIESI GROUP
Article | 27 September 1993
Italian pharmaceutical company Chiesi reported a 21.4% rise in sales for 1992 at 245.3 billion lire ($159.6 million), with a significant improvement in operating ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
